Please login to the form below

Not currently logged in
Email:
Password:

malaria

This page shows the latest malaria news and features for those working in and with pharma, biotech and healthcare.

GSK cues up regulatory filings for relapsing malaria drug

GSK cues up regulatory filings for relapsing malaria drug

GSK cues up regulatory filings for relapsing malaria drug. 60% of patients on tafenoquine combination remained relapse-free for six months. ... The vaccine targets P falciparum, the most deadly malaria parasite globally and the most prevalent form in

Latest news

More from news
Approximately 22 fully matching, plus 108 partially matching documents found.

Latest Intelligence

  • Waking the sleeping giant Waking the sleeping giant

    In Uganda, a malaria-specific app provides questions and answers relating to that disease, while in Mozambique another app greatly increases the efficacy of immunisation programmes by reminding users via text

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    developing a device that can detect malaria and give you a result in two minutes.

  • Opening up innovation Opening up innovation

    For GlaxoSmithKline its pharma open innovation efforts began with diseases of the developing world, such as malaria - where it offered researchers free access to a 'virtual library' of tens of thousands

  • Aiming high for women Aiming high for women

    6. Halt and start to reverse the spread and incidence of HIV/AIDS, malaria and other diseases - MISSED, although the number of new HIV/AIDS infections fell by 40% in

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Former PEPFAR head Mark Dybul to lead the Global Fund Former PEPFAR head Mark Dybul to lead the Global Fund

    Former PEPFAR head Mark Dybul to lead the Global Fund. Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics